An amplified 3D histological electrophoresis system that enables high-resolution analysis on high-throughput microwell arrays and ensures accuracy through a diffusion-analysis-supported amplification strategy that complements conventional histopathological diagnosis.
Abstract
Histopathological diagnosis remains the gold standard for cancer detection but is constrained by an inherent speed-accuracy trade-off, particularly for small biopsies. Here, we introduce an amplified three-dimensional (3D) histological electrophoresis system that enables high-resolution analysis on high-throughput microwell arrays and ensures accuracy through a diffusion-analysis-supported amplification strategy. By combining targeted labeling and electrophoretic separation, the system spatially maps tumor-specific proteins in tissue sections, reconstructing malignant tissue architecture without conventional morphologic assessment. In preclinical mouse models, it accurately delineated tumor contours, characterized necrotic regions, and comprehensively detected metastatic lymph nodes. In clinical specimens, it effectively distinguished cancerous versus noncancerous regions and identified intratumoral heterogeneity. This high-throughput amplified 3D histological electrophoresis system provides a rapid and fluorescence-based diagnostic approach that complements conventional histopathological diagnosis.
Abstract BACKGROUND Analyses of immune cell subsets and immune indices are gaining in importance. By combining molecular probe and immunohistochemical (IHC) analysis with laser ablation, the imaging mass cytometry (IMC) offers spatially high-dimensional in situ measurements in tissue slides with a cell resolution of 1µ...
S. Huang, Tian-Hao Zhou, Shao-Qian Du et al.· Research Square· 0 citations
Abstract The immune component of the tumor microenvironment (TME) is highly prognostic of patient outcome, further understanding of TME and the spatial organization of the immune cells within the TME is needed for better patient prognosis and treatment planning. Current brightfield immunohistochemistry techniques quant...
Kouther Noureddine, P. Gallagher, J. English et al.· ImmunoHorizons· 0 citations
Tissue biopsy and histopathological evaluation-considered the gold
standard-are traditionally used for cancer diagnosis; however, these procedures are invasive and
limited in their ability to accurately capture tumor heterogeneity. Liquid biopsy has emerged as
a minimally invasive alternative that enables molecular...
Ankur Vashishtha, Azeem Rizvi, Asif Ali et al.· Current Signal Transduction...· 0 citations
Accurate detection of lymph node (LN) metastases is critical for prognosis and surgical decision-making in head and neck squamous cell carcinoma (HNSCC) and other epithelial cancers. Standard histopathology examines only a small fraction of LN tissue, limiting sensitivity for micrometastases and isolated tumour cells....
T. Bergmann, Marianne Hölbling, M. Sudarsanam et al.· Journal of Pathology· 0 citations
This work introduces a biopsy-independent detection scheme for MYCN amplification, which holds promise for broad deployment in precision medicine and routine diagnostics.